AI Engines For more Details: Perplexity Kagi Labs You
Weight Management: Forskolin, the main active compound in Coleus forskohlii, has been studied for its potential to aid in weight loss and fat reduction. Forskolin may help increase the breakdown of stored fat in fat cells and stimulate the release of fatty acids, leading to improved body composition and weight loss.
Blood Sugar Regulation: Some research suggests that forskolin may help regulate blood sugar levels by stimulating the production of insulin and enhancing insulin sensitivity. This could be beneficial for individuals with diabetes or those at risk of developing diabetes.
Heart Health: Forskolin has been investigated for its potential cardiovascular benefits, including its ability to lower blood pressure and improve heart function. It may help relax blood vessels, increase blood flow, and reduce the risk of hypertension and heart disease.
Respiratory Health: Forskolin has bronchodilator properties, meaning it can help relax and widen the airways in the lungs. It has been studied for its potential to improve respiratory function and alleviate symptoms of conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Anti-inflammatory Effects: Forskolin has been shown to have anti-inflammatory properties, which may help reduce inflammation and alleviate symptoms of inflammatory conditions such as arthritis, inflammatory bowel disease (IBD), and skin disorders.
Neuroprotection: Some studies suggest that forskolin may have neuroprotective effects, helping to protect neurons from damage and promote brain health. It may have potential benefits for conditions such as Alzheimer's disease and Parkinson's disease.
Thyroid Function: Forskolin has been investigated for its potential to stimulate thyroid function and increase the production of thyroid hormones. This could be beneficial for individuals with hypothyroidism or those looking to support thyroid health.
Rank | Probiotic | Impact |
---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Allergies | 0.3 | -0.3 | |
Antiphospholipid syndrome (APS) | 0.5 | 0.5 | |
Asthma | 0.3 | 0.3 | 0 |
Autism | 0.5 | 0.5 | |
Brain Trauma | 0.5 | -0.5 | |
Celiac Disease | 1 | 0.5 | 1 |
Coagulation / Micro clot triggering bacteria | 0.3 | 0.3 | |
COVID-19 | 0.7 | 0.7 | |
deep vein thrombosis | 0.3 | 0.3 | |
Functional constipation / chronic idiopathic constipation | 0.3 | 0.3 | |
Hidradenitis Suppurativa | 0.5 | 0.5 | |
hyperglycemia | 0.5 | 0.5 | |
hypertension (High Blood Pressure | 0.5 | 0.5 | 0 |
Inflammatory Bowel Disease | 0.5 | 0.5 | |
Insomnia | 0.1 | 0.1 | |
Liver Cirrhosis | 0.8 | 0.5 | 0.6 |
Long COVID | 0.3 | 0.3 | |
Metabolic Syndrome | 0.5 | 0.5 | 0 |
Multiple system atrophy (MSA) | 0.2 | 0.2 | |
Obesity | 0.5 | 0.5 | 0 |
obsessive-compulsive disorder | 0.5 | 0.5 | |
Polycystic ovary syndrome | 0.3 | 0.3 | |
Psoriasis | 0.3 | 0.3 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.5 | 0.5 | |
Rosacea | 0.2 | 0.2 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.5 | 0.5 | |
Stress / posttraumatic stress disorder | 0.7 | 0.7 | |
Type 1 Diabetes | 0.5 | -0.5 | |
Type 2 Diabetes | 0.5 | 0.5 | 0 |
Ulcerative colitis | 0.5 | 0.5 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.